---
title: "RA Capital Management reports $292,129 Artiva Biotherapeutics common share purchase"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291186549.md"
description: "RA Capital Management purchased approximately $292,129 worth of Artiva Biotherapeutics common shares in open-market transactions priced between USD 8.88 and USD 8.98. Consequently, the RA Capital Healthcare Fund's indirect stake increased to 16,795,919 shares. The filing also notes additional indirect holdings across affiliated vehicles, including 826,832 shares held by Nexus Fund III."
datetime: "2026-06-29T20:21:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291186549.md)
  - [en](https://longbridge.com/en/news/291186549.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291186549.md)
generator: "portal-rs"
---

# RA Capital Management reports $292,129 Artiva Biotherapeutics common share purchase

-   RA Capital Management bought 32,876 Artiva Biotherapeutics common shares in open-market purchases at about USD 8.88 to USD 8.98. \* RA Capital Healthcare Fund’s stake rose to 16,795,919 shares held indirectly through the fund structure. \* The filing shows additional indirect holdings across affiliated RA Capital vehicles, including 826,832 shares in Nexus Fund III. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000711), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ARTV.US](https://longbridge.com/en/quote/ARTV.US.md)

## Related News & Research

- [Artiva Biotherapeutics CMO Subhashis Banerjee disposes of 8,222 shares for $98,730.32](https://longbridge.com/en/news/297569079.md)
- [RA Capital Management buys USD 456,297 of Artiva Biotherapeutics common shares](https://longbridge.com/en/news/294556883.md)
- [Hollencrest Capital Management Cuts Stake in Starbucks Corporation $SBUX](https://longbridge.com/en/news/297422817.md)
- [Brasada Capital Management LP Buys Shares of 6,469 Monolithic Power Systems, Inc. $MPWR](https://longbridge.com/en/news/297287972.md)
- [Delaware court enters USD 4 million judgment for Biohaven, Yale in trade secret case against RA Capital, Avilar](https://longbridge.com/en/news/297021096.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**